Tet-on systems for doxycycline-inducible gene expression

AT Das, L Tenenbaum, B Berkhout - Current gene therapy, 2016 - ingentaconnect.com
The tetracycline-controlled Tet-Off and Tet-On gene expression systems are used to regulate
the activity of genes in eukaryotic cells in diverse settings, varying from basic biological …

Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution

S Maisnier-Patin, DI Andersson - Research in microbiology, 2004 - Elsevier
Compensatory mutations, due to their ability to mask the deleterious effects of another
mutation, are important for the adaptation and evolution of most organisms. Resistance to …

The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. Mapping of the Nef binding surface by NMR

S Grzesiek, SJ Stahl, PT Wingfield, A Bax - Biochemistry, 1996 - ACS Publications
Using heteronuclear NMR spectroscopy, we demonstrate that a 13-residue peptide
(MSQIKRLLSEKKT) from the cytoplasmic tail of CD4 binds to Nef protein. This part of CD4 is …

Live attenuated, multiply deleted simian immunodeficiency virus causes AIDS in infant and adult macaques

TW Baba, V Liska, AH Khimani, NB Ray, PJ Dailey… - Nature medicine, 1999 - nature.com
A substantial risk in using live attenuated, multiply deleted viruses as vaccines against AIDS
is their potential to induce AIDS. A mutant of the simian immunodeficiency virus (SIV) with …

HIV vaccines

AJ McMichael - Annu. Rev. Immunol., 2006 - annualreviews.org
A prophylactic vaccine for HIV-1 is badly needed. Despite 20 years of effort, it is still a long
way off. However, considerable progress has been made in understanding the problem. The …

Control of SHIV-89.6 P-infection of cynomolgus monkeys by HIV-1 Tat protein vaccine

A Cafaro, A Caputo, C Fracasso, MT Maggiorella… - Nature medicine, 1999 - nature.com
Vaccine strategies aimed at blocking virus entry have so far failed to induce protection
against heterologous viruses. Thus, the control of viral infection and the block of disease …

Progress in the development of an HIV-1 vaccine

NL Letvin - Science, 1998 - science.org
Containment of the acquired immunodeficiency syndrome (AIDS) epidemic will require an
effective human immunodeficiency virus type 1 (HIV-1) vaccine. Accumulating evidence …

A review of vaccine research and development: the human immunodeficiency virus (HIV)

MP Girard, SK Osmanov, MP Kieny - Vaccine, 2006 - Elsevier
Since the discovery of AIDS in 1981, the global spread of HIV has reached pandemic
proportions, representing a global developmental and public health threat. The development …

Nef secretion into extracellular vesicles or exosomes is conserved across human and simian immunodeficiency viruses

RP McNamara, LM Costantini, TA Myers, B Schouest… - MBio, 2018 - Am Soc Microbiol
Extracellular vesicles (EVs) or exosomes have been implicated in the pathophysiology of
infections and cancer. The negative regulatory factor (Nef) encoded by simian …

HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction

RP Trible, L Emert-Sedlak, TE Smithgall - Journal of Biological Chemistry, 2006 - ASBMB
Nef is an HIV-1 virulence factor that promotes viral pathogenicity by altering host cell
signaling pathways. Nef binds several members of the Src kinase family, and these …